The Western NSW Local Health District (WNSWLHD) has announced that the palliative care trial underway at Uniting Parkwood will be extended until the end of June 2020.
WNSWLHD Chief Executive Scott McLachlan said, “The Western NSW Local Health District is committed to providing a service which is person-centred and supports families and carers of patients requiring palliative end of life care”.
“We started the Uniting Parkwood 12 month trial on March 25 2019, the trial was set to conclude on March 24, 2020, however, we received an extension of funding until June 30, 2020.
“This will ensure that there is sufficient time to assess the evaluation research that has been undertaken by independent researchers from NSW Regional Health Partners.
“The evaluation report is due for completion in February 2020 and it will be used to inform future decisions around funding and models of care for palliative and end of life care in Western NSW Local Health District.”
The Parkwood trial, which provides hospital-like care in a setting outside the hospital itself, was established to test how this model could be used by people from Orange and surrounding communities.
“Having choice about where to receive end of life care is very important. The different clinical and personal needs of each person means that we have to explore a range of options.
“Orange hospital provides excellent palliative care, and its specialist Palliative Care Team supports people who are being cared for at home, in aged care facilities, as well as in the hospital.
“We appreciate the community support we have received for this trial”. Mr McLachlan said.
The 2019-20 budget for WNSWLHD is $979 million, this is an increase of $35 million on the previous year's annualised budget.